Clinical Trial Update: A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 study evaluating L-PPDS with adjunctive Xalatan eye drops in individuals with ocular hypertension or open-angle …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• L-PPDS
• Xalatan (latanoprost)

Snippet

Sponsor: Mati Therapeutics Inc. | Conditions: Ocular Hypertension, Open-Angle Glaucoma | Phase 2 | Status: COMPLETED